WILTON, Conn., Oct. 24, 2016 -- Blue Buffalo Company (Nasdaq:BUFF) announced that Greg Reinhart, PhD, has joined the company as Senior Vice President, Research & Development. Dr. Reinhart will lead the Blue Buffalo R&D team that is responsible for clinical studies, upstream technology development, product innovation and scientific communications.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/e8e32722-0100-4e66-afc6-ab9d6a760db9
Dr. Reinhart comes from The Mathile Institute, a non-profit group focused on the nutritional health of children, where he applied his experience in companion animal and human health care industries to help alleviate hunger and malnutrition worldwide. Prior to the 9-year stint in the Mathile organization, Greg was responsible for technology development at Procter and Gamble’s global Pet Care business unit and The Iams Company before the acquisition by P&G.
“Dr. Reinhart has an impressive R&D background in animal and human nutrition,” said Bill Bishop, Founder and Chairman of Blue Buffalo. “Greg is passionate about enhancing the health of dogs and cats, and we’re excited about the scientific capabilities he brings to our growing business in both pet specialty retail and veterinary-exclusive, therapeutic diets.”
Greg will work with the R&D team at the company’s home office in Wilton, Conn. and the Blue Buffalo Heartland plant in Joplin, Mo. He will also provide leadership during the construction of the company’s new R&D technical center and manufacturing plant in Richmond, Ind., a $150 million investment in product supply and innovation.
“I am thrilled to bring my experience in scientific, evidence-based research to a company that is solely focused on the well-being of dogs and cats,” said Greg Reinhart, PhD. “It is a professional privilege to join the pet lovers at Blue Buffalo who provide nutritional advances that are most valued by clients and the veterinarians who care for their companion animals.”
Dr. Reinhart’s research interests include fatty acid metabolism, fiber fermentation, nutritional immunology, obesity, and the role of nutrition on cognition and well-being. During his tenure at The Iams Company, he organized multiple Iams Nutrition Symposia, which remain the largest international gathering of veterinary professionals, scientists and academicians dedicated solely to the sharing of new scientific findings in canine and feline nutrition.
Dr. Reinhart has published more than 230 scientific papers and abstracts in peer-reviewed journals. He is the co-editor of Recent Advances in Canine and Feline Nutrition, Volumes II and III, and an inventor on 14 U.S. patents.
Greg is an alumnus of The Ohio State University where he received a Bachelor of Science degree in Animal Science, a Master of Science degree in Non-Ruminant Nutrition, and PhD degree in Nutritional Biochemistry. In 2014, the Department of Animal Sciences at Ohio State elected Dr. Reinhart into its Hall of Fame for scientific contributions to the pet food industry and his influence on reducing childhood malnutrition. He is a Fellow of the American College of Nutrition and an active member in other professional scientific organizations.
About Blue Buffalo Company
Blue Buffalo, based in Wilton, CT, is the nation's leading natural pet food company, providing natural foods and treats for dogs and cats under its BLUE Life Protection Formula, BLUE Wilderness, BLUE Basics, BLUE Freedom and BLUE Natural Veterinary Diet lines. Paying tribute to its founding mission, the Company, through the Blue Buffalo Foundation, is also a leading sponsor of pet cancer awareness and of critical research studies of pet cancer, including causes, treatments and the role of nutrition, at leading veterinary medical schools and clinics across the United States. For more information about Blue Buffalo, visit the Company’s website at www.BlueBuffalo.com.
Contact Phil Cheevers VP, Communications 203-665-3234 [email protected]


Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth 



